For consortium members

What is the TRUSB-C

The TRUSB-C (TRUSTING User Board – Clinicians) consisting of nine clinicians with expertise in the treatment of schizophrenia and psychosis. Coordinated by the European Psychiatric Association (EPA), the group  provides expert advice to the TRUSTING consortium, and collaborates in co-design and co-development with the project’s The TRUSB-P (TRUSTING User Board  – Patients)

ROLES AND TASKS

The board ensures that patient and clinician perspectives shape research outcomes and their integration into practice by:

1 | Addressing User Needs and Building Trust in AI-Driven Clinical Applications

During the entire project, the TRUSB will be consulted for addressing and understanding the needs of (potential) users of SLP/NLP (*) technology in clinical applications and to a certain extent convincing end users of technology that capitalises on theoretically motivated, explainable and trustworthy AI.

(*)SLP= Speech and Language Processing. NLP=Natural Language Processing

2 | Co-Designing the RCT

The TRUSB will contribute to the co-design of the Random Clinical Trial (RCT). The RCT, as part of one of Workpackages (WP) in the project, will be co-designed by service users who have experienced psychosis and clinicians who treat citizens with psychosis. Many aspects of the RCTwill be confirmed upon dialogue with the User Board. Outcome measures of the RCT may be adjusted or extended on the initiative of the User Board.

3 | Engaging in Strategic Communication

The TRUSB will also be incentivised to participate in (strategic) communication in the beginning and during the project.

4 | Developing a Multilingual Educational Course for Informed User Engagement

Informed by the user-needs survey, an educational course will be developed in all six languages. The purpose of this course is to educate, motivate and empower participants (and their families and caretakers/support systems) to ensure that they use the relapse predictor. This course will be developed in concert with the TRUSTING User Board and adapted for use across all testing sites. An important goal of this course is to educate participants about the interpretation of test results. The global population has during the COVID-19 pandemic received a “crash course” in issues around testing such as false alarms and their consequences. Even so, participants will be trained to understand the feedback given.

MEET THE MEMBERS

Get to know the engaged clinicians contributing to this innovative project
Prof. Lars Lien

Clinician

Norway

Prof. Simavi Vahip

Clinician

Türkiye

Prof. Niels Mulder

Clinician

The Netherlands

Prof. Peter Falkai

Clinician

Germany

Dr. Uju Ugochukwu

Clinician

The United Kingdom

Prof. Umberto Volpe

Clinician

Italy

Prof. Pavel Mohr

Clinician

Czechia

Prof. Pierre Michel Llorca

Clinician

France

Prof. Sibel Çakır

Clinician

Türkiye